[Image courtesy of Adobe Stock]
The increasing complexities in clinical trials, including expanded patient populations, decentralized trials and new technologies, are directly impacting the amount of data and information available to clinical trial sponsors. Though this provides significant value to the industry, it presents a new challenge of consolidating disparate and siloed systems, improving standardization and unifying the explosion of data across clinical trials.Organizations are now faced with the need to centralize data and are increasingly adopting advanced data and analytics capabilities to bring efficiency to data centralization and democratization processes.
Regulatory challenges, incongruous data and increasing stakeholdersAs accountability shifts with regulatory guidelines, sponsors increasingly carry the burden of clinical trial oversight, taking responsibility for any unforeseen proble…